| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |